Pfizer to invest $1B in China over next five years
- The head of Pfizer’s (NYSE:PFE) operations in China said the global pharmaceutical company will invest $1B in China from 2025-2030 as part of a program to boost drug R&D in the country.
- Pfizer China President Jean-Christophe Pointeau recently said the